Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Elly A M Hassink"'
Autor:
Marit G A van Vonderen, Michiel A van Agtmael, Elly A M Hassink, Ana Milinkovic, Kees Brinkman, Suzanne E Geerlings, Matti Ristola, Arne van Eeden, Sven A Danner, Peter Reiss, MEDICLAS study group
Publikováno v:
PLoS ONE, Vol 4, Iss 5, p e5647 (2009)
Lipoatrophy is known to be associated with stavudine as part of the treatment for HIV infection, but it is less clear if this serious side effect is also related to other nucleoside reverse transcriptase inhibitors like zidovudine. We aimed to determ
Externí odkaz:
https://doaj.org/article/09bf51340a134ed5b30f035850d7d837
Autor:
A.I. van Sighem, F. De Wolf, Shuangjie Zhang, Peter Reiss, Elly A. M. Hassink, Clemens Richter, Jan M. Prins, R.H. Kauffmann, L. Gras, Anouk M. Kesselring
Publikováno v:
HIV Medicine. 16:265-272
OBJECTIVES: Certain non-AIDS-related diseases have been associated with immunodeficiency and HIV RNA levels in HIV-infected patients on combination antiretroviral therapy (cART). We aimed to investigate these associations in patients not yet on cART,
Autor:
Marit G. A. van Vonderen, Yvo M. Smulders, Peter Reiss, Elly A. M. Hassink, Sven A. Danner, Coen D.A. Stehouwer, Michiel A. van Agtmael
Publikováno v:
The Journal of Infectious Diseases, 199(8), 1186-1194. Oxford University Press
Journal of infectious diseases, 199(8), 1186-1194. Oxford University Press
Journal of infectious diseases, 199(8), 1186-1194. Oxford University Press
The risk of cardiovascular disease in human immunodeficiency virus (HIV)-infected patients is an increasing concern. We studied the changes in vascular properties after the initiation of combination antiretroviral therapy (cART) as well as the contri
Autor:
Sven A. Danner, Hans P. Sauerwein, Michiel A. van Agtmael, Regje M. E. Blümer, Peter Reiss, Marit G. A. van Vonderen, Mariëtte T. Ackermans, Jussi Sutinen, Elly A. M. Hassink, Hannele Yki-Järvinen
Publikováno v:
AIDS, 22(2), 227-236. Lippincott Williams and Wilkins
Blumer, R M, van Vonderen, M G, Sutinen, J, Hassink, E, Ackermans, M, van Agtmael, M A, Yki-Jarvinen, H, Danner, S A, Reiss, P & Sauerwein, H P 2008, ' Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy ', AIDS, vol. 22, no. 2, pp. 227-236 . https://doi.org/10.1097/qad.0b013e3282f33557
AIDS (London, England), 22(2), 227-236. Lippincott Williams and Wilkins
Blumer, R M, van Vonderen, M G, Sutinen, J, Hassink, E, Ackermans, M, van Agtmael, M A, Yki-Jarvinen, H, Danner, S A, Reiss, P & Sauerwein, H P 2008, ' Zidovudine/lamivudine contributes to insulin resistance within 3 months of starting combination antiretroviral therapy ', AIDS, vol. 22, no. 2, pp. 227-236 . https://doi.org/10.1097/qad.0b013e3282f33557
AIDS (London, England), 22(2), 227-236. Lippincott Williams and Wilkins
Background: Patients with antiretroviral therapy (ART)-associated lipodystrophy frequently have disturbances in glucose metabolism associated with insulin resistance. It is not known whether changes in body composition are necessary for the developme
Autor:
Peter Reiss, Berthe L. F. van Eck-Smit, Elly A. M. Hassink, Selwyn H. Lowe, Jan C. C. Borleffs, Joep M. A. Lange
Publikováno v:
HIV clinical trials, 8(5), 337-344. Taylor and Francis Ltd.
PURPOSE: To objectively assess changes in body fat distribution in a subgroup of antiretroviral therapy-naïve participants in a randomized comparative trial of regimens including a nucleoside analogue backbone of didanosine with either lamivudine or
Autor:
Reshma Saskia Autar, Umaporn Siangphoe, Jintanat Ananworanich, Joep M. A. Lange, David M. Burger, Praphan Phanuphak, Ferdinand W. N. M. Wit, Marta Boffito, Anton Pozniak, Elly A. M. Hassink, David A. Cooper, Kiat Ruxrungtham
Publikováno v:
Journal of antimicrobial chemotherapy, 56(5), 908-913. Oxford University Press
Objectives: Differential exposure to saquinavir/ritonavir may lead to therapy failure. The objective was to identify factors that influence variability of saquinavir/ritonavir plasma concentrations. Methods: Saquinavir/ritonavir data, dosed as 1600/1
Autor:
R. W. ten Kate, Selwyn H. Lowe, Elly A. M. Hassink, Job R. Juttmann, Peter P. Koopmans, I. van der Tweel, Lange Jm, Jan C. C. Borleffs, G. Schreij, Annemarie M. J. Wensing, Clemens Richter
Publikováno v:
Clinical trials, 6(5), 235-245. SAGE Publications Inc.
Hiv Clinical Trials, 6, 235-45
Hiv Clinical Trials, 6, 5, pp. 235-45
HIV clinical trials, 6(5), 235-245. Taylor and Francis Ltd.
Hiv Clinical Trials, 6, 235-45
Hiv Clinical Trials, 6, 5, pp. 235-45
HIV clinical trials, 6(5), 235-245. Taylor and Francis Ltd.
Contains fulltext : 47519.pdf (Publisher’s version ) (Closed access) BACKGROUND: To improve the dosing frequency and pill burden of antiretroviral therapy, we compared two once-daily dosed regimens to a twice-daily dosed regimen. METHOD: HIV-1-infe
Autor:
Aeumporn Srigritsanapol, Joep M. A. Lange, Bharat Damle, Elly A. M. Hassink, Richard M. W. Hoetelmans, Praphan Phanuphak, Kiat Ruxrungtham, Theshinee Chuenyam, Pimolrat Thaithumyanon, Chantana Boonrod, Sompop Limpongsanurak, Chokechai Rongkavilit, David A. Cooper
Publikováno v:
Antimicrobial Agents and Chemotherapy. 45:3585-3590
We evaluated the pharmacokinetics of stavudine (d4T) and didanosine (ddI) in neonates. Eight neonates born to human immunodeficiency virus-infected mothers were enrolled to receive 1 mg of d4T per kg of body weight twice daily and 100 mg of ddI per m
Autor:
Mireille J. Serlie, Regje M. E. Blümer, Marit G. A. van Vonderen, Hannele Yki-Järvinen, Michiel A. van Agtmael, Sven A. Danner, Peter Reiss, Jussi Sutinen, Hans P. Sauerwein, Mariëtte T. Ackermans, Elly A. M. Hassink
Publikováno v:
Jaids-journal of Acquired Immune Deficiency Syndromes, 53(2), 186-193. LIPPINCOTT WILLIAMS & WILKINS
Journal of acquired immune deficiency syndromes (1999), 53(2), 186-193. Lippincott Williams and Wilkins
Journal of Acquired Immune Deficiency Syndromes, 53(2), 186-193. Lippincott Williams and Wilkins
van Vonderen, M G A, Blumer, R M E, Hassink, E A M, Sutinen, J, Ackermans, M T, van Agtmael, M A, Yki-Jarvinen, H, Danner, S A, Serlie, M J, Sauerwein, H P & Reiss, P 2010, ' Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy ', Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 2, pp. 186-193 . https://doi.org/10.1097/QAI.0b013e3181c190f4
Journal of acquired immune deficiency syndromes (1999), 53(2), 186-193. Lippincott Williams and Wilkins
Journal of Acquired Immune Deficiency Syndromes, 53(2), 186-193. Lippincott Williams and Wilkins
van Vonderen, M G A, Blumer, R M E, Hassink, E A M, Sutinen, J, Ackermans, M T, van Agtmael, M A, Yki-Jarvinen, H, Danner, S A, Serlie, M J, Sauerwein, H P & Reiss, P 2010, ' Insulin Sensitivity in Multiple Pathways Is Differently Affected During Zidovudine/Lamivudine-Containing Compared With NRTI-Sparing Combination Antiretroviral Therapy ', Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 2, pp. 186-193 . https://doi.org/10.1097/QAI.0b013e3181c190f4
Objective: The extent and manner by which HIV nucleoside reverse transcriptase inhibitors contribute to insulin resistance is unclear. We evaluated the effect of zidovudine/lamivudine (ZDV/3TC) on glucose metabolism. Methods: combination antiretrovir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7fe14c80fc7d8442a681c4e1592186d2
https://cris.maastrichtuniversity.nl/en/publications/a22611af-f07b-453f-912c-348786075ed5
https://cris.maastrichtuniversity.nl/en/publications/a22611af-f07b-453f-912c-348786075ed5
Autor:
John J.P. Kastelein, Hans P. Sauerwein, René Oesterholt, Elly A. M. Hassink, Alejandro Arenas-Pinto, Stephen P. Storfer, Remco Franssen, Kees Brinkman, Barbara A. Hutten, Erik S.G. Stroes, Peter Reiss, Raaj R. Sankatsing, Mariëtte T. Ackermans
Publikováno v:
Arteriosclerosis Thrombosis and Vascular Biology, 29(9), 1336-41. LIPPINCOTT WILLIAMS & WILKINS
Arteriosclerosis, thrombosis, and vascular biology, 29(9), 1336-1341. Lippincott Williams and Wilkins
Arteriosclerosis, thrombosis, and vascular biology, 29(9), 1336-1341. Lippincott Williams and Wilkins
Objective— The purpose of this study was to investigate the mechanism by which the nonnucleoside reverse transcriptase inhibitor (NNRTI) nevirapine (NVP) increases high-density lipoprotein cholesterol (HDLc) in treatment-experienced human immunodef